Stereotactic radioablation for ventricular tachycardia.
Herzschrittmacherther Elektrophysiol
; 33(1): 49-54, 2022 Mar.
Article
em En
| MEDLINE
| ID: mdl-34825951
Non-invasive stereotactic radioablation of ventricular tachycardia (VT) substrate has been proposed as a novel treatment modality for patients not eligible for catheter-based ablation or in whom this approach has failed. Initial clinical results are promising with good short-term efficacy in VT suppression and tolerable side effects. This article reviews the current clinical evidence for cardiac radioablation and gives an overview of important preclinical and translational results. Practical guidance is provided, and a cardiac radioablation planning and treatment workflow based on expert consensus and the authors' institutional experience is set out.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Taquicardia Ventricular
/
Ablação por Cateter
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article